National Health Commission: Public hospitals should realize three 'turns'

On May 8, Ma Xiaowei, director of the National Health Commission, said that the management of public hospitals should be strengthened to shift from scale expansion to quality benefit, from extensive management to fine management, and from investment in hospital development and construction to expansion of distribution. Ma Xiaowei further explained that the purpose of public hospitals changing from scale expansion to quality benefit is to improve medical quality; from extensive management to fine management is to improve efficiency; and from investment in hospital development and construction to expansion of distribution is to improve treatment. In addition, the performance appraisal of tertiary public hospitals should be carried out in an all-round way, and the supervision of the whole industry should be strengthened. In the tenth year of the improvement of new doctors, the hierarchical diagnosis and treatment system is continually advancing, and the discussion on the comprehensive reform of public hospitals has attracted much attention. Industry insiders believe that under this background, public hospitals should realize three "turns", releasing the signal of further deepening health care reform under the principles of government-led, public welfare-led and public hospital-led.
According to Ma Xiaowei, solving the problem of "difficult and expensive to see a doctor" is the main direction of deepening medical reform. To crack down on the "expensive medical treatment", we must make joint efforts and joint reform of the "three doctors". Strengthening the management of public hospitals is one of them. In addition, we need to improve the drug policy and the national essential drug system. Ma Xiaowei pointed out that the basic idea is to maximize the integration of existing health resources and build an integrated medical service model. First, we need to accelerate the construction of medical conjoined and medical community. In the near future, we should focus on building 100 Urban Medical conjoined bodies and 500 County communities. Two, we should strengthen the construction of county hospitals, implement a new round of county level hospitals' service capability upgrading projects, and promote 90% of the rural medical problems in the county level; three, the development of "Internet + medical health", which has already covered all poverty-stricken counties on the basis of telemedicine. We will continue to cover all medical communities and medical communities and extend them to villages and villages. Fourthly, we will provide contracted services for family doctors and highlight key groups and diseases.
Looking for chemical products? Let suppliers reach out to you!
2026-07-14
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Maximum reduction of 81%! 22,000 down to $6,300 Large group of consumables with collective price cuts
-
Overview of China's medical device import and export trade in 2021
-
5 Billion! Strong Growth! Top 1 Sample Hospital Variety
-
Do You Know the Real Benefits of Eating Bird's Nest?
-
Polycarbonate PC turns out to have so many uses
-
Nation helping meet global demand for medical supplies
-
Yanan Petrochemical converted polypropylene medical non-woven fabric material
-
Medicare Payment: Grass-roots co-ordinated payment
-
Xinlitai heavy new product will be approved soon
-
The original research price of 3.5 billion pound varieties dropped by 74%
Recommend Reading
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
Aficamten Beats Metoprolol in Obstructive HCM, Strengthening Case Ahead of FDA Decision
-
AstraZeneca Targets Year-End Filing for Novel Hypertension Drug Baxdrostat
-
FDA Clears Sanofi’s Wayrilz (rilzabrutinib) for Adult ITP; U.S. Launch in September
-
Acesulfame Potassium: Safety, Side Effects, and Food Uses
-
Sell Signal Alert! Melamine Drops Sharply to "Low Position" in 10 Days, Short-term Momentum Weakens
-
DMF Supply Tightens in Early April, Prices Remain Strong
-
Geopolitical Deadlock and Tightening Inventories Drive Crude Oil Prices Higher on Friday
-
Formic Acid Moving Averages Set to Cross Upward—Rising Trend May Be About to Begin